MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE (memantine and donepezil) by Macleods Pharms is extended-release capsules contain two approved medications: memantine hydrochloride and donepezil hydrochloride. Approved for moderate to severe dementia of the alzheimer's type in patients stabilized on 10 mg of donepezil hydrochloride once daily. First approved in 2025.
Drug data last refreshed 14h ago
extended-release capsules contain two approved medications: memantine hydrochloride and donepezil hydrochloride. Each of those medications is postulated to have a different mechanism in Alzheimer's disease. Memantine Persistent activation of central nervous system NMDA receptors by the excitatory…
Worked on MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE at Macleods Pharms? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.